The 3rd Transparency & Aggregate Spend Summit, held on June 3-4, 2024, in Philadelphia, focused on the latest challenges and solutions in HCP spend reporting compliance for the life sciences industry. Attendees delved into new state requirements, global transparency, and data analytics, with special attention to CMS audits. The speaking faculty included colleagues from Johnson & Johnson, Roche Diagnostics, and Takeda.
The event featured interactive breakout groups and expert-led sessions, fostering deep discussions on improving data capture and compliance processes. Key topics included strategies for managing state reporting requirements and leveraging data analytics for compliance efficiency. The summit provided a…
Learn more today: https://dgevents.com/event/transparency-aggregate-spend-summit/
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com
InvestorWire is powered by IBN
